*´ºÉ«Ö±²¥

The result compared with a profit of $32 million or 32 cents per diluted share a year earlier.

Sales totalled $1.17 billion, up from $1.03 billion in the same quarter last year.

On an adjusted basis, Cascades says it earned 20 cents per share in its latest quarter compared with an adjusted loss of a penny per share in the same quarter last year.

Cascades CEO Mario Plourde says the company's third-quarter performance was in line with expectations notwithstanding the fact that its tissue segment continued to face unprecedented cost inflation and reduced productivity due to labour scarcity and inefficiencies.

This report by ´ºÉ«Ö±²¥was first published Nov. 10, 2022.

Companies in this story: (TSX:CAS)